Universal Phase Vaccine Enters Phase I Trial

That's the thing about this vaccine. The M2e protein is conserved by a-strain influenza, so even the mutants would have that protein. Since the antibody specifically targets that protein it should fight off mutant strains as well. Of course if the mutant evolves and sheds itself of that protein a new vaccine would be needed it seems like.